tilator Friday, 11/10/17 05:12:56 PM Re: AngeloFoca post# 31212 0 Post # of 37556 Quote:$6.6 million 4th Qtr 2017 Tight Estimate You are right, but the big question is why on earth MNK can sell only 1-2% compared to Accord and Lupin sales even though they got approval together? This leaves much to gain to MNK. If MNK got 1000% growth right now, it still would sell only 10% compared to Accord and 20% compared to Lupin. Well - the numbers are prescription counts, not dollars, but anyway. I suppose you got the point.